Rico Eisner1, Norman Lippmann2, Christoph Josten3, Arne C Rodloff2, Daniel Behrendt4. 1. Department of Anaesthesiology and Critical Care Medicine, Trauma Surgery and Plastic Surgery, Universitätsklinikum Leipzig, Leipzig, Germany. 2. Institute for Medical Microbiology and Epidemiology of Infectious Diseases, Trauma Surgery and Plastic Surgery, Universitätsklinikum Leipzig, Leipzig, Germany. 3. Department of Orthopedics, Trauma Surgery and Plastic Surgery, Universitätsklinikum Leipzig, Leipzig, Germany. 4. Roland-Klinik, Bremen, Germany.
Abstract
Background: While ubiquitously multi-resistant bacteria are on the rise, peri-operative antimicrobial prophylaxis in trauma and near-to-bone surgical procedures has only been changed slightly during the last 25 years. Recent clinical studies concerning the bacterial spectrum and efficacy of antimicrobial treatment in infected trauma surgical patients are rare. The aim of the study was analysis of the contemporary bacterial spectrum and its antimicrobial resistance including the assessment of the appropriateness of peri-operative antimicrobial prophylaxis with cefuroxime. Methods: Patients of a level-I academic trauma center who underwent open or arthroscopic surgery because of a recent trauma necessitating the use of bone-near metal implants were included in the study. All patients in whom a surgical site infection (SSI) had developed during six weeks post-operatively necessitating surgical debridement and had positive microbiologic culture results from an intra-operative surgical site swab were analyzed, retrospectively. In particular, age, gender, date and duration of surgical interventions, and patient's related risk factors were collected, and infecting agents and their minimum inhibitory concentration values for 34 selected antimicrobial agents were evaluated. An SSI occurring later than 6 weeks post-operatively and patients with chronic and septic wounds were excluded. Statistical analysis was performed with SPSS® (IBM, Armonk, NY). Results: There were 438 pathogens cultured in specimens from 303 enrolled patients (female = 140, male = 163). The most frequent pathogens were Staphylococcus aureus (27.1%), S. epidermidis (20.6%), Enterococcus faecalis (13.6%), Escherichia coli (5.1%), and Pseudomonas aeruginosa (3.7%) accounting for 303 isolates. Of those, 89 (29.4%) were multi-resistant. Of the S. epidermidis isolates, 79.8% (n = 71) were resistant against Oxacillin and thus against most beta-lactam antibiotic agents. Altogether, only 44.1% of the infecting organisms were susceptible to cefuroxime, the antimicrobial agent most often being used for prophylactic purposes. Conclusion: Standardized antimicrobial prophylaxis with cephalosporins has to be reconsidered critically. Multi-resistant species such as S. epidermidis are an increasing challenge in trauma operations.
Background: While ubiquitously multi-resistant bacteria are on the rise, peri-operative antimicrobial prophylaxis in trauma and near-to-bone surgical procedures has only been changed slightly during the last 25 years. Recent clinical studies concerning the bacterial spectrum and efficacy of antimicrobial treatment in infected trauma surgical patients are rare. The aim of the study was analysis of the contemporary bacterial spectrum and its antimicrobial resistance including the assessment of the appropriateness of peri-operative antimicrobial prophylaxis with cefuroxime. Methods:Patients of a level-I academic trauma center who underwent open or arthroscopic surgery because of a recent trauma necessitating the use of bone-near metal implants were included in the study. All patients in whom a surgical site infection (SSI) had developed during six weeks post-operatively necessitating surgical debridement and had positive microbiologic culture results from an intra-operative surgical site swab were analyzed, retrospectively. In particular, age, gender, date and duration of surgical interventions, and patient's related risk factors were collected, and infecting agents and their minimum inhibitory concentration values for 34 selected antimicrobial agents were evaluated. An SSI occurring later than 6 weeks post-operatively and patients with chronic and septic wounds were excluded. Statistical analysis was performed with SPSS® (IBM, Armonk, NY). Results: There were 438 pathogens cultured in specimens from 303 enrolled patients (female = 140, male = 163). The most frequent pathogens were Staphylococcus aureus (27.1%), S. epidermidis (20.6%), Enterococcus faecalis (13.6%), Escherichia coli (5.1%), and Pseudomonas aeruginosa (3.7%) accounting for 303 isolates. Of those, 89 (29.4%) were multi-resistant. Of the S. epidermidis isolates, 79.8% (n = 71) were resistant against Oxacillin and thus against most beta-lactam antibiotic agents. Altogether, only 44.1% of the infecting organisms were susceptible to cefuroxime, the antimicrobial agent most often being used for prophylactic purposes. Conclusion: Standardized antimicrobial prophylaxis with cephalosporins has to be reconsidered critically. Multi-resistant species such as S. epidermidis are an increasing challenge in trauma operations.
Authors: Hanna Santos Marques; Glauber Rocha Lima Araújo; Filipe Antônio França da Silva; Breno Bittencourt de Brito; Paulo Victor Dias Versiani; Jaqueline Silva Caires; Thiago de Carvalho Milet; Fabrício Freire de Melo Journal: World J Clin Cases Date: 2021-04-06 Impact factor: 1.337
Authors: Aram Avila-Herrera; James B Thissen; Nisha Mulakken; Seth A Schobel; Michael D Morrison; Xiner Zhou; Scott F Grey; Felipe A Lisboa; Desiree Unselt; Shalini Mabery; Meenu M Upadhyay; Crystal J Jaing; Eric A Elster; Nicholas A Be Journal: Sci Rep Date: 2022-08-15 Impact factor: 4.996
Authors: Emanuela Roscetto; Marco Masi; Matilde Esposito; Roberta Di Lecce; Antonella Delicato; Lucia Maddau; Viola Calabrò; Antonio Evidente; Maria Rosaria Catania Journal: Toxins (Basel) Date: 2020-07-08 Impact factor: 4.546
Authors: Evi M Morandi; Selina Winkelmann; Lucie Dostal; Isabel Radacki; Ulrich M Rieger; Benedikt Bauer; Ralph Verstappen; Dolores Wolfram; Thomas Bauer Journal: Int Wound J Date: 2021-06-09 Impact factor: 3.315